Log In
BCIQ
Print this Print this
 

METAmphizon (NM0147)

  Manage Alerts
Collapse Summary General Information
Company Nanomerics Ltd.
DescriptionNano-enabled orally active form of Amphotericin B
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationLeishmaniasis
Indication DetailsLeishmaniasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today